- Home
- SCLX vs INDO Comparison
SCLX vs INDO Comparison
Compare SCLX & INDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- INDO
- Stock Information
- Founded
- SCLX 2011
- INDO 2018
- Country
- SCLX United States
- INDO Indonesia
- Employees
- SCLX N/A
- INDO N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- INDO Oil & Gas Production
- Sector
- SCLX Health Care
- INDO Energy
- Exchange
- SCLX Nasdaq
- INDO Nasdaq
- Market Cap
- SCLX 33.9M
- INDO 35.1M
- IPO Year
- SCLX N/A
- INDO 2019
- Fundamental
- Price
- SCLX $6.38
- INDO $2.96
- Analyst Decision
- SCLX Strong Buy
- INDO
- Analyst Count
- SCLX 3
- INDO 0
- Target Price
- SCLX $367.50
- INDO N/A
- AVG Volume (30 Days)
- SCLX 100.7K
- INDO 8.6M
- Earning Date
- SCLX 08-12-2025
- INDO 07-15-2025
- Dividend Yield
- SCLX N/A
- INDO N/A
- EPS Growth
- SCLX N/A
- INDO N/A
- EPS
- SCLX N/A
- INDO N/A
- Revenue
- SCLX $50,710,000.00
- INDO $2,667,508.00
- Revenue This Year
- SCLX $107.00
- INDO N/A
- Revenue Next Year
- SCLX $82.52
- INDO N/A
- P/E Ratio
- SCLX N/A
- INDO N/A
- Revenue Growth
- SCLX 7.79
- INDO N/A
- 52 Week Low
- SCLX $3.60
- INDO $2.06
- 52 Week High
- SCLX $73.50
- INDO $7.95
- Technical
- Relative Strength Index (RSI)
- SCLX 60.64
- INDO 45.89
- Support Level
- SCLX $6.00
- INDO $2.85
- Resistance Level
- SCLX $6.76
- INDO $3.30
- Average True Range (ATR)
- SCLX 0.42
- INDO 0.53
- MACD
- SCLX 0.11
- INDO -0.14
- Stochastic Oscillator
- SCLX 82.06
- INDO 2.35
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About INDO Indonesia Energy Corporation Limited
Indonesia Energy Corp Ltd is an oil and gas exploration and production company focused on Indonesia. The company is an independent energy company engaged in the oil and gas business and holds two oil and gas assets through its subsidiaries in Indonesia: The Kruh Block and the Citarum Block. It has also identified a potential third exploration block known as the Rangkas area. . Its portfolio consists of Kruh Block and Citarum Block. The company generates its revenue from oil and gas sales.